Terms: = Brain cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
25 results:
1. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract] [Full Text] [Related]
2. Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis.
Li A; Liu W; Cao P; Zheng Y; Bu Z; Zhou T
World Neurosurg; 2017 May; 101():236-246. PubMed ID: 28104521
[TBL] [Abstract] [Full Text] [Related]
3. An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.
Direk N; Williams S; Smith JA; Ripke S; Air T; Amare AT; Amin N; Baune BT; Bennett DA; Blackwood DHR; Boomsma D; Breen G; Buttenschøn HN; Byrne EM; Børglum AD; Castelao E; Cichon S; Clarke TK; Cornelis MC; Dannlowski U; De Jager PL; Demirkan A; Domenici E; van Duijn CM; Dunn EC; Eriksson JG; Esko T; Faul JD; Ferrucci L; Fornage M; de Geus E; Gill M; Gordon SD; Grabe HJ; van Grootheest G; Hamilton SP; Hartman CA; Heath AC; Hek K; Hofman A; Homuth G; Horn C; Jan Hottenga J; Kardia SLR; Kloiber S; Koenen K; Kutalik Z; Ladwig KH; Lahti J; Levinson DF; Lewis CM; Lewis G; Li QS; Llewellyn DJ; Lucae S; Lunetta KL; MacIntyre DJ; Madden P; Martin NG; McIntosh AM; Metspalu A; Milaneschi Y; Montgomery GW; Mors O; Mosley TH; Murabito JM; Müller-Myhsok B; Nöthen MM; Nyholt DR; O'Donovan MC; Penninx BW; Pergadia ML; Perlis R; Potash JB; Preisig M; Purcell SM; Quiroz JA; Räikkönen K; Rice JP; Rietschel M; Rivera M; Schulze TG; Shi J; Shyn S; Sinnamon GC; Smit JH; Smoller JW; Snieder H; Tanaka T; Tansey KE; Teumer A; Uher R; Umbricht D; Van der Auwera S; Ware EB; Weir DR; Weissman MM; Willemsen G; Yang J; Zhao W; Tiemeier H; Sullivan PF
Biol Psychiatry; 2017 Sep; 82(5):322-329. PubMed ID: 28049566
[TBL] [Abstract] [Full Text] [Related]
4. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Villani A; Shore A; Wasserman JD; Stephens D; Kim RH; Druker H; Gallinger B; Naumer A; Kohlmann W; Novokmet A; Tabori U; Tijerin M; Greer ML; Finlay JL; Schiffman JD; Malkin D
Lancet Oncol; 2016 Sep; 17(9):1295-305. PubMed ID: 27501770
[TBL] [Abstract] [Full Text] [Related]
5. Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B
Togao O; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Yoneyama M; Honda H
Magn Reson Med; 2017 Jun; 77(6):2272-2279. PubMed ID: 27385636
[TBL] [Abstract] [Full Text] [Related]
6. [Incidence and mortality of cancer in Zhejiang province in 2009].
Li HZ; Mao WM; Wang XH; Yu CD; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):592-6. PubMed ID: 24304949
[TBL] [Abstract] [Full Text] [Related]
7. High-resolution whole-genome analysis of skull base chordomas implicates fhit loss in chordoma pathogenesis.
Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
[TBL] [Abstract] [Full Text] [Related]
8. The promoter hypermethylation status of GATA6, MGMT, and fhit in glioblastoma.
Cecener G; Tunca B; Egeli U; Bekar A; Tezcan G; Erturk E; Bayram N; Tolunay S
Cell Mol Neurobiol; 2012 Mar; 32(2):237-44. PubMed ID: 21928112
[TBL] [Abstract] [Full Text] [Related]
9. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
Fields EC; Damek D; Gaspar LE; Liu AK; Kavanagh BD; Waziri A; Lillehei K; Chen C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):51-7. PubMed ID: 21035955
[TBL] [Abstract] [Full Text] [Related]
10. fhit gene sequence variants and reduced fhit protein expression in glioblastoma multiforme.
Cecener G; Tunca B; Egeli U; Bekar A; Guler G; Tolunay S; Aksoy K
Cell Mol Neurobiol; 2010 Mar; 30(2):301-7. PubMed ID: 19760177
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of mutations and expression of the fhit gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract] [Full Text] [Related]
12. DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.
McAvoy S; Ganapathiraju S; Perez DS; James CD; Smith DI
Cytogenet Genome Res; 2007; 119(3-4):196-203. PubMed ID: 18253029
[TBL] [Abstract] [Full Text] [Related]
13. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
[TBL] [Abstract] [Full Text] [Related]
14. Non-random inactivation of large common fragile site genes in different cancers.
McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
[TBL] [Abstract] [Full Text] [Related]
15. Lack of association of fragile histidine triad (fhit) polymorphisms with lung cancer in the Korean population.
Jung HY; Sung JS; Whang YM; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Sung HJ; Choi IK; Oh SC; Seo JH; Kim YH
J Hum Genet; 2007; 52(8):668. PubMed ID: 17609851
[TBL] [Abstract] [Full Text] [Related]
16. fhit protein is preferentially expressed in the nucleus of monocyte-derived cells and its possible biological significance.
Zhao P; Hou N; Lu Y
Histol Histopathol; 2006 Sep; 21(9):915-23. PubMed ID: 16763940
[TBL] [Abstract] [Full Text] [Related]
17. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract] [Full Text] [Related]
18. Promoter hypermethylation profile of RASSF1A, fhit, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract] [Full Text] [Related]
19. A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.
Lewis KD; Gibbs P; O'Day S; Richards J; Weber J; Anderson C; Zeng C; Baron A; Russ P; Gonzalez R
Cancer Invest; 2005; 23(4):303-8. PubMed ID: 16100942
[TBL] [Abstract] [Full Text] [Related]
20. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.
Galmarini CM; Kamath K; Vanier-Viornery A; Hervieu V; Peiller E; Falette N; Puisieux A; Ann Jordan M; Dumontet C
Br J Cancer; 2003 Jun; 88(11):1793-9. PubMed ID: 12771997
[TBL] [Abstract] [Full Text] [Related]
[Next]
